Investigating the 3D structure of proteins related to SARS-CoV-2 and other infectious diseases
Official title: Centers for Research on Structural Biology of Infectious Diseases: SARS-CoV-2
Funded at Northwestern University at Chicago · NIH-11160417 · Data updated 2026-11-12
This study is looking at the tiny structures of proteins related to COVID-19 and other infectious diseases to help find better treatments and vaccines, which could ultimately benefit patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 1, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $3,052,532 |
| NIH project number | 75N93022C00035-P00010-9999-5 |
| Project ID | NIH-11160417 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by COVID-19 or those at risk of emerging infectious diseases.
✕Less likely to help
Patients with non-infectious diseases or those not affected by COVID-19 or related pathogens may not receive any benefit from this research.
What this research studies
This research focuses on using advanced structural biology techniques to determine the three-dimensional atomic structures of proteins associated with SARS-CoV-2 and other emerging infectious diseases. By understanding these structures, researchers aim to uncover the molecular functions of these proteins, which could lead to new insights in treating infectious diseases. The project involves high-throughput methods to analyze these proteins, which are critical for developing effective therapies and vaccines. Patients may benefit from the findings as they could lead to improved treatments for COVID-19 and similar diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments and vaccines for COVID-19 and other infectious diseases.
How similar studies have gone: Other research has shown success in using structural biology approaches to understand infectious diseases, indicating that this methodology is both promising and tested.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Satchell, Karla — Northwestern University at Chicago
- Study coordinator: Satchell, Karla
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.